Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge (Q80966865)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

Isabelle P Hunziker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Stephanie Harkins

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Ralph Feuer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Christopher T Cornell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J Lindsay Whitton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

196-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

Engineering poliovirus as a vaccine vector for the expression of diverse antigens

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Enterovirus sequences resembling coxsackievirus A2 detected in stool and spleen from a girl with fatal myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie A9 focal encephalitis associated with acute infantile hemiplegia and porencephaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie B virus infection and onset of childhood diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Effects of P2 cleavage site mutations on poliovirus polyprotein processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

A fatal case of coxsackievirus B4 meningoencephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

A cluster of cases of neonatal coxsackievirus B meningitis and myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Chronic Progressive Poliomyelitis Secondary to Vaccination of an Immunodeficient Child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie B3 myocarditis in 4 cases of suspected sudden infant death syndrome: diagnosis by immunohistochemical and molecular-pathologic investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie B virus infection in idiopathic dilated cardiomyopathy: clinical and pharmacological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Murine forebrain anomalies induced by coxsackievirus B3 variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Direct interferon-γ-mediated protection caused by a recombinant coxsackievirus B3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Expression of an antigenic adenovirus epitope in a group B coxsackievirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Pathogenetic differences between coxsackie A and B virus infections in newborn mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

The group B coxsackieviruses and myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Primary structure, gene organization and polypeptide expression of poliovirus RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackie virus-induced acute pancreatitis in a long-term dialysis patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

The role of B lymphocytes in coxsackievirus B3 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Polio vaccines and the cessation of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Perinatal echovirus and group B coxsackievirus infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Cell-free, de novo synthesis of poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Persistent fever as the only manifestation of chronic coxsackievirus B4 infection in the brain of a human immunodeficiency virus type 1-infected child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Infectious causes of acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Choriomeningitis and Myocarditis in an Adolescent with Isolation of Coxsackie B-5 Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackieviruses and pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackieviruses and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackievirus myocarditis--with special reference to acute and chronic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Encephalomyelitis in primary hypogammaglobulinaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Enterovirus infections: diagnosis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

The growth of four human and animal enteroviruses in the central nervous systems of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

DNA immunization of mice against the VP1 capsid protein of coxsackievirus B4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Chimeric coxsackie B3 virus genomes that express hybrid coxsackievirus-poliovirus 2B proteins: functional dissection of structural domains involved in RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Picornavirus 2A proteinase-mediated stimulation of internal initiation of translation is dependent on enzymatic activity and the cleavage products of cellular proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

Chronic enteroviral meningoencephalitis in agammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.09.035

7 January 2021

10.1016/J.VIROL.2004.09.035

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15527846%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference